Latest News

Evogene Reports Fourth Quarter and Annual 2009 Financial Results

Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results

NeuroSearch A/S - Financial statements 2009

ExonHit Therapeutics reports 2009 annual results

Javelin Pharmaceuticals Reports Fiscal Results for the Year Ended 2009

Alexza Reports 2009 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update

Cannasat Therapeutics Reports Results for the Year Ended December 31, 2009

Recordati: 2009 accounts approved by the board. Net income EUR 110.6 million. Dividend per share EUR 0.275 (+10%)

ORCHID CELLMARK TO ANNOUNCE FOURTH QUARTER AND YEAR-END 2009 FINANCIAL RESULTS ON MARCH 11, 2010

Opexa Therapeutics Reports Year End 2009 Financial Results

More news... | RSS Feed...

Most Viewed

NxStage Reports Fourth Quarter and Full-Year 2009 Financial Results That Exceed Company Guidance

Full-year accounts for 2009

BioSphere Medical Reports Fourth Quarter Revenue of $8.4 Million and a Narrowed Net Loss of $0.02 Per Share

BIOPHARMACEUTICAL REVENUES UP 53.3% EBITDA IMPROVES FOR SECOND CONSECUTIVE YEAR

CML HealthCare Income Fund Announces Release Date for Fiscal 2009 Fourth Quarter Financial Results

Teva Reports Record Full Year 2009 And Fourth Quarter Results

AMAG Pharmaceuticals Announces Fourth Quarter and Year End 2009 Financial Results

NicOx 2009 Financial Results

ViroPharma to Release 2009 Fourth Quarter and Full Year Financial Results on February 24, 2010

Biovail Reports Fourth Quarter, Year-End 2009 Financial Results

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire